Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: A preliminary evaluation of recurrence of disease

Howard A. Kader, Stephen C Raynor, Rose Young, Stuart S. Kaufman, Jon Vanderhoof, Elizabeth I. Ruby, David R. Mack

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Recurrence of Crohn's disease alter surgery is a common occurrence, pointing to the need for a strategy to prevent recurrent disease. We report the postoperative course of 10 patients who required intestinal resections for complications related to Crohn's disease. Methods: All patients had a Pediatric Crohn's Disease Activity Index score of 10 or greater. Among these patients, 5 began treatment with 6-mercaptopurine in the perioperative period. All 10 had received various combinations of prednisone and salicylate compounds. Patients who were given 6 mercaptopurine did not discontinue the medication until 2 years after the surgery. Results: To date, none of the five patients who were placed on 6 mercaptopurine have had recurrence of their Crohn's disease (mean disease-free period 32.6 ± 18.4 months). Among those five patients not receiving 6-mercaptopurine there have been three relapses (mean time to relapse 3.7 ± 1.2 months). Logrank sum analyses of Kaplan-Meier survival curves show benefit to patients receiving 6-mercaptopurine in preventing relapses after intestinal resection (p < 0.05). Conclusions: Although the underlying pathophysiologic reasons leading to the high relapse rate after intestinal surgery in Crohn's disease are unknown, we conclude that treatment with 6-mercaptopurine in the perioperative period may be warranted to help prevent the recurrence of Crohn's disease after surgery.

Original languageEnglish (US)
Pages (from-to)93-97
Number of pages5
JournalJournal of pediatric gastroenterology and nutrition
Volume25
Issue number1
DOIs
StatePublished - Jul 1 1997

Fingerprint

6-Mercaptopurine
Perioperative Period
Crohn disease
relapse
Crohn Disease
Recurrence
surgery
resection
prednisone
salicylates
Salicylates
Kaplan-Meier Estimate
Prednisone
drug therapy
Therapeutics

Keywords

  • 6-mercaptopurine
  • Children
  • Crohn's disease
  • Intestinal resection
  • Relapse

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Gastroenterology

Cite this

Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period : A preliminary evaluation of recurrence of disease. / Kader, Howard A.; Raynor, Stephen C; Young, Rose; Kaufman, Stuart S.; Vanderhoof, Jon; Ruby, Elizabeth I.; Mack, David R.

In: Journal of pediatric gastroenterology and nutrition, Vol. 25, No. 1, 01.07.1997, p. 93-97.

Research output: Contribution to journalArticle

Kader, Howard A. ; Raynor, Stephen C ; Young, Rose ; Kaufman, Stuart S. ; Vanderhoof, Jon ; Ruby, Elizabeth I. ; Mack, David R. / Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period : A preliminary evaluation of recurrence of disease. In: Journal of pediatric gastroenterology and nutrition. 1997 ; Vol. 25, No. 1. pp. 93-97.
@article{100acc3b2ccb4bfc9337eeecfa0f27cf,
title = "Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: A preliminary evaluation of recurrence of disease",
abstract = "Background: Recurrence of Crohn's disease alter surgery is a common occurrence, pointing to the need for a strategy to prevent recurrent disease. We report the postoperative course of 10 patients who required intestinal resections for complications related to Crohn's disease. Methods: All patients had a Pediatric Crohn's Disease Activity Index score of 10 or greater. Among these patients, 5 began treatment with 6-mercaptopurine in the perioperative period. All 10 had received various combinations of prednisone and salicylate compounds. Patients who were given 6 mercaptopurine did not discontinue the medication until 2 years after the surgery. Results: To date, none of the five patients who were placed on 6 mercaptopurine have had recurrence of their Crohn's disease (mean disease-free period 32.6 ± 18.4 months). Among those five patients not receiving 6-mercaptopurine there have been three relapses (mean time to relapse 3.7 ± 1.2 months). Logrank sum analyses of Kaplan-Meier survival curves show benefit to patients receiving 6-mercaptopurine in preventing relapses after intestinal resection (p < 0.05). Conclusions: Although the underlying pathophysiologic reasons leading to the high relapse rate after intestinal surgery in Crohn's disease are unknown, we conclude that treatment with 6-mercaptopurine in the perioperative period may be warranted to help prevent the recurrence of Crohn's disease after surgery.",
keywords = "6-mercaptopurine, Children, Crohn's disease, Intestinal resection, Relapse",
author = "Kader, {Howard A.} and Raynor, {Stephen C} and Rose Young and Kaufman, {Stuart S.} and Jon Vanderhoof and Ruby, {Elizabeth I.} and Mack, {David R.}",
year = "1997",
month = "7",
day = "1",
doi = "10.1097/00005176-199707000-00016",
language = "English (US)",
volume = "25",
pages = "93--97",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period

T2 - A preliminary evaluation of recurrence of disease

AU - Kader, Howard A.

AU - Raynor, Stephen C

AU - Young, Rose

AU - Kaufman, Stuart S.

AU - Vanderhoof, Jon

AU - Ruby, Elizabeth I.

AU - Mack, David R.

PY - 1997/7/1

Y1 - 1997/7/1

N2 - Background: Recurrence of Crohn's disease alter surgery is a common occurrence, pointing to the need for a strategy to prevent recurrent disease. We report the postoperative course of 10 patients who required intestinal resections for complications related to Crohn's disease. Methods: All patients had a Pediatric Crohn's Disease Activity Index score of 10 or greater. Among these patients, 5 began treatment with 6-mercaptopurine in the perioperative period. All 10 had received various combinations of prednisone and salicylate compounds. Patients who were given 6 mercaptopurine did not discontinue the medication until 2 years after the surgery. Results: To date, none of the five patients who were placed on 6 mercaptopurine have had recurrence of their Crohn's disease (mean disease-free period 32.6 ± 18.4 months). Among those five patients not receiving 6-mercaptopurine there have been three relapses (mean time to relapse 3.7 ± 1.2 months). Logrank sum analyses of Kaplan-Meier survival curves show benefit to patients receiving 6-mercaptopurine in preventing relapses after intestinal resection (p < 0.05). Conclusions: Although the underlying pathophysiologic reasons leading to the high relapse rate after intestinal surgery in Crohn's disease are unknown, we conclude that treatment with 6-mercaptopurine in the perioperative period may be warranted to help prevent the recurrence of Crohn's disease after surgery.

AB - Background: Recurrence of Crohn's disease alter surgery is a common occurrence, pointing to the need for a strategy to prevent recurrent disease. We report the postoperative course of 10 patients who required intestinal resections for complications related to Crohn's disease. Methods: All patients had a Pediatric Crohn's Disease Activity Index score of 10 or greater. Among these patients, 5 began treatment with 6-mercaptopurine in the perioperative period. All 10 had received various combinations of prednisone and salicylate compounds. Patients who were given 6 mercaptopurine did not discontinue the medication until 2 years after the surgery. Results: To date, none of the five patients who were placed on 6 mercaptopurine have had recurrence of their Crohn's disease (mean disease-free period 32.6 ± 18.4 months). Among those five patients not receiving 6-mercaptopurine there have been three relapses (mean time to relapse 3.7 ± 1.2 months). Logrank sum analyses of Kaplan-Meier survival curves show benefit to patients receiving 6-mercaptopurine in preventing relapses after intestinal resection (p < 0.05). Conclusions: Although the underlying pathophysiologic reasons leading to the high relapse rate after intestinal surgery in Crohn's disease are unknown, we conclude that treatment with 6-mercaptopurine in the perioperative period may be warranted to help prevent the recurrence of Crohn's disease after surgery.

KW - 6-mercaptopurine

KW - Children

KW - Crohn's disease

KW - Intestinal resection

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=0030793278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030793278&partnerID=8YFLogxK

U2 - 10.1097/00005176-199707000-00016

DO - 10.1097/00005176-199707000-00016

M3 - Article

C2 - 9226535

AN - SCOPUS:0030793278

VL - 25

SP - 93

EP - 97

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 1

ER -